AVMA news
EPA, FDA weigh oversight overhaul for animal parasite products
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
AVMA news
Convention sessions, statement touch on environmental impact of veterinary medicine
Speakers at AVMA Convention 2023 will talk about the impacts of climate change and how environmental sustainability is an increasingly important topic…
AVMA news
WVC features AVMA sessions, research results
The AVMA offered sessions at the 2023 WVC Annual Conference as part of a year-old partnership with Viticus Group, the organization that hosts WVC.…
AVMA news
Remaining medically important antimicrobials transitioning to prescription status
The Food and Drug Administration is reminding stakeholders that certain over-the-counter antimicrobial products for animals are transitioning to…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
JAVMA news
Editing Animals
Recent gene-editing technologies are being used to create mice that model human genetic diseases, Holstein cattle lacking horns, and current research…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
JAVMA news
Program created to help researchers market their discoveries
The Texas A&M University College of Veterinary Medicine & Biomedical Sciences is getting $1.2 million to create a nationwide training program that…
AVMA news
FDA warns manufacturers, distributors of unapproved antimicrobials for animals
The U.S. Food and Drug Administration (FDA) on December 14 announced it has issued nine warning letters to manufacturers and distributors of…
AVMA news
Honeybee vaccine receives conditional license from USDA
The U.S. Department of Agriculture has granted a conditional license for a vaccine to protect honeybees against American foulbrood. The only…
JAVMA news
Antimicrobial sales rise despite pending changes
Agreements between federal regulators and pharmaceutical companies are expected to reduce antimicrobial use in agriculture by the end of this year.
JAVMA news
Pig drug may be withdrawn over residues
Food and Drug Administration officials are working to rescind approval of a swine-use drug that may leave carcinogenic residues in pork.
JAVMA news
Drug compounding position statement adopted
Compounding services have become more abundant as veterinary pharmacies multiply and enjoy financial success.
JAVMA news
Human drug shortages noted on new Web site
TAKE NOTICE Human drug shortages noted on new Web site When veterinarians find it hard to obtain an…
AVMA news
Mars acquires Heska in $1.3B deal
Mars Inc. and Heska Corp. have entered into a agreement that Mars will buy the diagnostic veterinary equipment firm for $1.3 billion.
JAVMA news
NIFA awards $2.3 million to relieve veterinary shortages
The competitive grants awarded by the Department of Agriculture’s National Institute of Food and Agriculture are funded through the new Veterinary…
JAVMA news
AABP honors standouts
In Vancouver, the AABP recognized seven members deserving of the association's top honors.
JAVMA news
Q&A with Dr. Elizabeth A. Curry-Galvin
Dr. Elizabeth A. Curry-Galvin, outgoing deputy chief executive officer of the AVMA, answers questions from JAVMA News.
JAVMA news
FDA to require species-specific antimicrobial data
Pharmaceutical companies will need to give federal authorities data that could be used to compare antimicrobial consumption and
JAVMA news
Old, new deputy CEO see AVMA moving profession forward
What kept Dr. Elizabeth A. Curry-Galvin on the staff of the AVMA for two decades?
JAVMA news
BSE: Could it happen here? Experts say probably not
As BSE continues its spread in Europe, US authorities are fine-tuning defensive actions to prevent the arrival and spread of the disease